World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00703716
Date of registration: 20/06/2008
Prospective Registration: No
Primary sponsor: Integra LifeSciences Services
Public title: Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX TRAUMAX
Scientific title: Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX
Date of first enrolment: May 2008
Target sample size: 190
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00703716
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     CHIRON Philippe
Address: 
Telephone:
Email:
Affiliation:  CHU Rangueil, Toulouse, FRANCE
Key inclusion & exclusion criteria

Inclusion Criteria:

- Man or woman

- Age > 18

- with a trochanteric fracture whom surgeon advised the use of a screw-plate TRAUMAX

Exclusion Criteria:

- Patient with an acute infection

- Patient with a major osseous deterioration which not allows a correct support of the
screws in the bone

- Patient with an ASA score of 4 or 5

- Patient whom the time between the fracture and the surgery could be higher than 8
days



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Hip Fracture
Intervention(s)
Primary Outcome(s)
The rate of complication due to the device [Time Frame: 6 months after surgery]
The consolidation rate [Time Frame: 6 months after surgery]
Secondary Outcome(s)
The evolution of the functional scores (Parker, ADL, Katz, Robinson) between before the fracture and after the intervention. [Time Frame: 3 and 6 months after surgery]
operating time [Time Frame: during the surgery]
PMA score [Time Frame: 3 and 6 months after surgery]
The radiological position of the device [Time Frame: 5 days, 3 and 6 months]
The duration of the use of the amplifier of brilliancy during the intervention [Time Frame: during the surgery]
Secondary ID(s)
RECON-EMEA-06
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history